[{"Assets_0_Q3_USD":1203727000.0,"CommonStockSharesOutstanding_0_Q3_shares":51815992.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-411980000.0,"NetIncomeLoss_1_Q3_USD":-179958000.0,"NetIncomeLoss_3_Q3_USD":-511585000.0,"StockholdersEquity_0_Q3_USD":1081071000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":51704687.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":50496489.0,"Ticker":"SAGE","CIK":"1597553","name":"SAGE THERAPEUTICS, INC.","OfficialName":"Sage Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2034401653.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]